✦ LIBER ✦
Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology Group (ECOG) trial E3590
✍ Scribed by Wakelee, Heather A.; Stephenson, Patricia; Keller, Steven M.; Wagner, Henry; Herskovic, Arnold; Komaki, Ritsuko; Marks, Randolph S.; Perry, Michael C.; Livingston, Robert B.; Johnson, David H.
- Book ID
- 119319117
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 227 KB
- Volume
- 48
- Category
- Article
- ISSN
- 0169-5002
No coin nor oath required. For personal study only.